Prognostic value of cyclooxygenase-2 expression in squamous cell carcinoma of the bladder

Journal of Urology

Volumn 185, Issue 3, 2011, Pages 1112-1117

  Youssef, Ramy F ^a,b   Shariat, Shahrokh F ^a,c   Kapur, Payal ^a   Kabbani, Wareef ^a   Mosbah, Ahmed ^b   Abol Enein, Hassan ^b   Ghoniem, Mohamed ^b   Lotan, Yair ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MANSOURA UNIVERSITY   (Egypt)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

carcinoma; cyclooxygenase 2; cystectomy; schistosomiasis; squamous cell; urinary bladder

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER SQUAMOUS CELL CARCINOMA; BRIGHT FIELD MICROSCOPY; CANCER GRADING; CANCER RECURRENCE; CANCER SURGERY; CYSTECTOMY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 79851508954     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.10.036     Document Type: Article

References (28)

1. D.M. Parkin The global burden of urinary bladder cancer Scand J Urol Nephrol 218 Suppl 2008 12
2. S.A. Fedewa, A.S. Soliman, and K. Ismail Incidence analyses of bladder cancer in the Nile delta region of Egypt Cancer Epidemiol 33 2009 176
3. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225
4. D.S. Michaud Chronic inflammation and bladder cancer Urol Oncol 25 2007 260
5. M. El-Sebaie, M.S. Zaghloul, and G. Howard Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management Int J Clin Oncol 10 2005 20
6. A.A. Shokeir Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment BJU Int 93 2004 216
7. D. Leibovici, H.B. Grossman, and C.P. Dinney Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival J Clin Oncol 23 2005 5746
8. M. Moussa, Z. Omran, and M. Nosseir Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma APMIS 117 2009 45
9. S.S. El-Sheikh, S. Madaan, and A. Alhasso Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancer BJU Int 88 2001 921
10. T. Shirahama, and C. Sakakura Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder Clin Cancer Res 7 2001 558
11. O.A. Hammam, A.A. Aziz, and M.S. Roshdy Possible role of cyclooxygenase-2 in schistosomal and non-schistosomal-associated bladder cancer Medscape J Med 10 2008 60
12. Y. Cao, and S.M. Prescott Many actions of cyclooxygenase-2 in cellular dynamics and in cancer J Cell Physiol 190 2002 279
13. K. Muller-Decker, and G. Furstenberger The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis Mol Carcinog 46 2007 705
14. D. Wang, and R.N. Dubois Prostaglandins and cancer Gut 55 2006 115
15. D. Pereg, and M. Lishner Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer J Intern Med 258 2005 115
16. R.S. Pruthi, E. Derksen, and K. Gaston Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer Urology 64 2004 637
17. T. Shirahama, J. Arima, and S. Akiba Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder Cancer 92 2001 188
18. S.F. Shariat, J.H. Kim, and G.E. Ayala Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder J Urol 169 2003 938
19. S.F. Shariat, K. Matsumoto, and J. Kim Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder J Urol 170 2003 985
20. P. Wadhwa, A.K. Goswami, and K. Joshi Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder Int Urol Nephrol 37 2005 47
21. V. Margulis, S.F. Shariat, and R. Ashfaq Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder J Urol 177 2007 1163
22. M.A. Ghoneim, M.M. el-Mekresh, and M.A. el-Baz Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases J Urol 158 1997 393
23. M.A. Ghoneim, M. Abdel-Latif, and M. el-Mekresh Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later J Urol 180 2008 121
24. Y. Lotan, A. Gupta, and S.F. Shariat Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy J Clin Oncol 23 2005 6533
25. S.F. Shariat, R.S. Svatek, and D. Tilki International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy BJU Int 105 2010 1402
26. Clinical trials National Institutes of Health http://www.clinicaltrials. gov/ Accessed February 2010
27. M.D. Holmes, W.Y. Chen, and L. Li Aspirin intake and survival after breast cancer J Clin Oncol 28 2010 1467
28. C.G. Rogers, G.S. Palapattu, and S.F. Shariat Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder J Urol 175 2006 2048